Overview
Martina Seiffert practices in Heidelberg, Germany. Ms. Seiffert is rated as an Elite expert by MediFind in the treatment of Chronic B-Cell Leukemia (CBCL). Her top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Leukemia, and Small Lymphocytic Lymphoma (SLL).
Her clinical research consists of co-authoring 65 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 50 articles in the study of Chronic B-Cell Leukemia (CBCL).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Chronic B-Cell Leukemia (CBCL)Ms. Seiffert isElite. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)
- Distinguished
- LeukemiaMs. Seiffert isDistinguished. Learn about Leukemia.
- Small Lymphocytic Lymphoma (SLL)Ms. Seiffert isDistinguished. Learn about Small Lymphocytic Lymphoma (SLL).
- Experienced
- Adult T-Cell LeukemiaMs. Seiffert isExperienced. Learn about Adult T-Cell Leukemia.
- B-Cell LymphomaMs. Seiffert isExperienced. Learn about B-Cell Lymphoma.
- GliomaMs. Seiffert isExperienced. Learn about Glioma.
- Hairy Cell Leukemia (HCL)Ms. Seiffert isExperienced. Learn about Hairy Cell Leukemia (HCL).
- NecrosisMs. Seiffert isExperienced. Learn about Necrosis.
- Non-Hodgkin LymphomaMs. Seiffert isExperienced. Learn about Non-Hodgkin Lymphoma.